Clinical Trial Update: AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AtriCure's minimally invasive surgical ablation for atrial fibrillation (RESTORE IIB) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: AtriCure, Inc. | Conditions: Atrial Fibrillation | Phase 2 | Status: WITHDRAWN